Ryvu Therapeutics SA (0RKT) Revenue

0 Followers

Ryvu Therapeutics SA Revenue

Ryvu Therapeutics SA had a revenue of 11.99M in the quarter ending Jun 30, 2026, with -29.28%. This bring the company's revenue in the last twelve months to 61.86M, Increased -0.67%. In the fiscal year ending Dec 31, 2025, Ryvu Therapeutics SA had annual revenue of 62.25M with -20.15% growth.

Revenue (ttm)

61.86M

Revenue Growth

-11.57%

P/S Ratio

5.87

Revenue/Employee

zł273,044

Employees

228

Market Cap

zł365.30M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	62.25M	-15.71M	-20.15%
Dec 31, 2024	77.97M	31.11M	+66.38%
Dec 31, 2023	46.86M	8.06M	+20.76%
Dec 31, 2022	38.80M	27.62M	+246.89%
Dec 31, 2021	11.19M	-4.23M	-27.43%
Dec 31, 2020	15.41M	-27.15M	-63.79%
Mar 31, 2020	42.57M	-34.64M	-44.87%
Dec 31, 2018	77.21M	-10.61M	-12.09%
Dec 31, 2017	87.82M	―	―